1 Indices for cost-effectiveness on safety
1.1 Introduction
The purpose of this appendix is to suggest a set of cost-effectiveness criteria, which
may be used in FSA studies. The use of these cost-effectiveness criteria would enable
the FSA studies to be conducted in a more consistent manner, making results and the way
they were achieved better comparable and understandable. This appendix provides
clarification on available criteria to assess the cost-effectiveness of risk control
options so-called cost-effectiveness criteria. It is also recommended how these criteria
should be applied.
1.2 Terminology
1.2.1 DALY (Disability Adjusted Life Years)/QALY (Quality Adjusted Life Years):
The basic idea of a QALY is one year of perfect health-life expectancy to be worth 1,
but regards one year of less than perfect health-life expectancy as less than 1. Unlike
QALY, the DALY assigns that one year of perfect health-life to be 0 and one year of less
than perfect as more than 0.
1.2.2 LQI (Life Quality Index): The index for expressing the social, health,
environment and economic dimensions of the quality of life at working conditions. The
LQI can be used to comment on key issues that affect people and contribute to the public
debate about how to improve the quality of life in our communities.
1.2.3 GCAF (Gross Cost of Averting a Fatality): A cost-effectiveness measure in
terms of ratio of marginal (additional) cost of the risk control option to the reduction
in risk to personnel in terms of the fatalities averted; i.e.
1.2.4 NCAF (Net Cost of Averting a Fatality): A cost-effectiveness measure in
terms of ratio of marginal (additional) cost, accounting for the economic benefits of
the risk control option to the reduction in risk to personnel in terms of the fatalities
averted, i.e.
1.3 NCAF and GCAF
1.3.1 The common criteria used for estimating the cost-effectiveness of risk reduction
measures are NCAF and GCAF. In principle there are several approaches to derive NCAF and
GCAF criteria:
-
.1 Observation of the Willingness-To-Pay to avert a fatality;
-
.2 Observation of past decisions and the costs involved with them; and
-
.3 Consideration of societal indicators such as the Life Quality Index (LQI).
For further detail, reference is made to Nathwani et al., Rackwitz (2002).
1.3.2 The proposed values for NCAF and GCAF in table 2 were derived by considering
societal indicators (refer to document MSC 72/16, UNDP 1990, Lind 1996). They are
provided for illustrative purposes only. The specific values selected as appropriate and
used in an FSA study should be explicitly defined. These criteria given in table 2 are
not static, but should be updated every year according to the average risk free rate of
return (approximately 5%) or by use of the formula based on LQI (Nathwani et al. (1996),
Skjong and Ronold (1998, 2002), Rackwitz (2002 a,b).
|
NCAF [US $]
|
GCAF [US $]
|
criterion covering risk of fatality, injuries and ill health
|
3 million
|
3 million
|
criterion covering only risk of fatalityfootnote
|
1.5 million
|
1.5 million
|
criterion covering only risk of injuries and ill healthfootnote
|
1.5 million
|
1.5 million
|
1.3.3 It is recommended that the following approach is applied in using GCAF and NCAF
criteria:
-
.1 GCAF or NCAF:
In principle, either of the two criteria can be used. However, it is recommended
to firstly consider GCAF instead of NCAF. The reason is that NCAF also takes into
account economic benefits from the RCOs under consideration. This may be misused
in some cases for pushing certain RCOs, by considering more economic benefits on
preferred RCOs than on other RCOs.
If the cost-effectiveness of an RCO is in the range of criterion, then NCAF may be
also considered.
-
.2 Negative NCAF:
Recent FSA studies have come up with some risk control options (RCO) where the
associated NCAF was negative. Assuming that the RCO has a positive risk reduction
potential ΔR (i.e. reduces the risk), a negative NCAF means that the benefits in
monetary units are higher than the costs associated with the RCO. It should be
noted that a high negative NCAF with positive ΔR may result from either of the
following two facts:
-
.1 the benefits are much higher than the costs associated with the RCO; or
-
.2 the RCO has a low risk reduction potential ΔR (the lower ΔR, the higher
is the NCAF, refer to formula (2)).
1.3.4 Therefore, RCOs with high negative NCAFs should always be considered in connection
with the associated risk reduction capability.
QALY and/or DALY
1.3.5 The QALY or DALY criterion can be used for risks that only involve injuries and/or
ill health, but no fatalities. It can be derived from the GCAF criterion, by assuming
that one prevented fatality implies 35 Quality Adjusted Life Years gained (refer to
document MSC 72/16):
2 Environmental risk evaluation criteria on prevention of oil spill from ships
2.1 Noting that the most appropriate conversion formula to use will depend on the
specific scope of each FSA to be performed, a general approach to be followed is
outlined in the following suggested examples.
Cost for compensating oil spills
2.2 Consolidated oil spill database based on IOPCF data; US Data; and Norwegian data.
2.3 Figure 1 shows the data of the consolidated oil spill database in terms of specific
costs per tonne spilled (figure 5 of document MEPC 62/INF.24). Further information with
respect to the basis of the database can be found in document MEPC 62/INF.24. It should
be acknowledged that the consolidated oil spill database has limitations and possible
deficiencies. These are described in document MEPC 62/INF.24 and may also involve
incomplete or missing data on costs or other information.

Figure 1: All specific oil spill cost data in 2009 USD (spill cost per tonne)
Source: document MEPC 62/INF.24
2.4 The submitter of the FSA can amend this database with new oil spill data, however,
this amendment should be properly documented.
2.5 Some regression formulae derived from the consolidated oil spill database are
summarized in table 1 in which V is spill size in tonnes.
Table 1: Regression formulae derived from the consolidated database
Dataset
|
f(V)=Total Spill Cost (TSC) (2009 US
dollars)
|
Reference
|
All spills
|
67,275 V 0.5893
|
MEPC 62/INF.24
|
V>0.1 tonnes
|
42,301 V 0.7233
|
MEPC 62/18footnote
|
2.6 FSA analysts are free to use other conversion formulae, so long as these are well
documented by the data. For example, if an FSA is considering only small spills, the
submitter may filter the data and perform his or her own regression analysis.
2.7 It is recommended that the FSA analyst use the following formula to estimate the
societal oil spill costs (SC) used in the analysis:
2.8 The values of both assurance and uncertainty factors should be well documented. In
addition, if value of FAssurance and
FUncertainty other than 1.0 are used, a cost-effective
analysis using FAssurance = 1.0 and FUncertainty
= 1.0 should be included in the FSA results, for reference.
2.9 In order to consider the large scatter, the FSA analyst may perform a regression to
determine a function f(V) that covers a percentile different than 50% and
document it in the report.
Application in RCO evaluation
2.10 The FSA analyst should perform a cost-benefit and cost-effectiveness evaluation of
the RCOs identified and provide all relevant details in the report, as outlined
below.
RCOs affecting oil spills only
2.11 In case an RCO affects oil spills only:
-
RCO is cost-effective if ΔC < ΔSC
-
ΔC = Expected cost of the RCO
-
ΔSC = (Expected SC without the RCO) – (Expected SC with the RCO) =
Expected benefit of the RCO
RCOs affecting both safety and environment
2.12 In case of RCOs addressing both safety and environment the following formula is
recommended:
-
NCAF = (ΔC – ΔSC) / ΔPLL
-
In the above,
-
ΔC = Expected cost of the RCO
-
ΔSC = (Expected SC without the RCO) – (Expected SC with the
RCO) = Expected benefit of the RCO
-
ΔPLL = Expected reduction of fatalities due to the RCO
2.13 The criteria for NCAF are as per table 2 of appendix 7 of document MSC 83/INF.2.
2.14 In case there is an economic benefit (ΔB), ΔC should be replaced by ΔC-ΔB.
2.15 It is also emphasized that all cost and benefit components of the cost-benefit or
cost-effectiveness inequality should be shown in an FSA study for better transparency.
Other indices
2.16 The user is free to develop new approaches, taking into account the objectives of
the FSA.